ARS Pharmaceuticals, Inc Net Asset Quality Index
ARS Pharmaceuticals, Inc net asset quality index. ARS Pharmaceuticals, Inc (SPRY) has a Net Asset Quality Index of 34.9% as of December 2025. This metric measures the proportion of total assets financed by shareholders' equity — total assets of $327.65 Million minus total liabilities of $213.39 Million yields net assets of $114.26 Million. A higher index indicates a stronger, lower-leverage balance sheet. See SPRY book value for net asset value and shareholders' equity analysis.
Quality Index
Net Assets
Total Assets
Total Liabilities
Net Asset Quality Index of ARS Pharmaceuticals, Inc (2018–2025)
Net asset quality index of ARS Pharmaceuticals, Inc from 2018 to 2025. This chart shows how ARS Pharmaceuticals, Inc's Net Asset Quality Index has evolved across 8 annual periods from 2018 to 2025. As of December 2025, the index stands at 34.9%, representing net assets of $114.26 Million against total assets of $327.65 Million USD. Check ARS Pharmaceuticals, Inc PP&E and investment ratio to assess the company's strategic physical and investment asset allocation.
ARS Pharmaceuticals, Inc Net Asset Quality Index by Year (2018–2025)
ARS Pharmaceuticals, Inc net asset quality index by year from 2018 to 2025. The table below presents the year-by-year Net Asset Quality Index for ARS Pharmaceuticals, Inc from 2018 to 2025, covering 8 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. For live market cap and overall valuation, see ARS Pharmaceuticals, Inc (SPRY) total market value.
| Year | Quality Index | Net Assets (USD) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2025 | 34.9% | $114.26 Million | $327.65 Million | $213.39 Million | ▼ -38.3 pp |
| 2024 | 73.1% | $256.80 Million | $351.15 Million | $94.36 Million | ▼ -25.8 pp |
| 2023 | 99.0% | $230.76 Million | $233.19 Million | $2.43 Million | ▲ +2.0 pp |
| 2022 | 97.0% | $272.89 Million | $281.44 Million | $8.55 Million | ▲ +147.9 pp |
| 2021 | -50.9% | $-31.27 Million | $61.45 Million | $92.72 Million | ▲ +2.3 pp |
| 2020 | -53.2% | $-14.05 Million | $26.41 Million | $40.46 Million | ▼ -17.4 pp |
| 2019 | -35.8% | $-5.60 Million | $15.65 Million | $21.25 Million | ▼ -101.9 pp |
| 2018 | 66.1% | $18.20 Million | $27.55 Million | $9.35 Million | — |